BioSig Installs PURE EP(tm) System at Massachusetts General Hospital

August 4, 2020

BioSig Awarded CAGE Code by the Systems for Award Management (SAM)

August 3, 2020

BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020

July 30, 2020

BioSig Technologies to Participate in LD Micro’s Zooming with LD

July 23, 2020

ViralClear Announces Formation of Its Scientific Advisory Board

July 20, 2020

BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit

July 17, 2020

BioSig Technologies, Inc. Adopts Stockholder Rights Agreement

July 16, 2020

Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites

July 13, 2020

BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government

July 10, 2020

ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19

July 8, 2020